Senti Bio (SNTI)science reported positive initial clinical data from a Phase 1 clinical trial of SENTI-202, a potential first-in-class Logic Gated off-the-shelf chimeric antigen receptor natural kille ...
The system is designed to keep pace with emerging and illicit drugs. In April 2022, an OOC company called CN Bio introduced the PhysioMimix “in-a-box” reagent kit. This kit is specifically designed ...